Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
2310005E 10Rik | |
BC026843 |
RIKEN cDNA 2310005E10 gene, mRNA (cDNA clone IMAGE:4487182), complete cds. [BC026843] |
KLA | .70 |
.65 |
.65 |
.65 |
.83 |
.90 |
.89 |
| ATP | 1.00 |
.95 |
.75 |
.31 |
.29 |
.58 |
.80 |
| KLA/ATP | .69 |
.54 |
.49 |
.28 |
.36 |
.56 |
.53 |
|
2310005E 10Rik | |
NM_172398 |
RIKEN cDNA 2310005E10 gene (2310005E10Rik), mRNA [NM_172398] |
KLA | .78 |
.71 |
.71 |
.71 |
.69 |
.90 |
.82 |
| ATP | 1.01 |
.95 |
1.18 |
.89 |
.68 |
.44 |
.62 |
| KLA/ATP | .71 |
.70 |
.88 |
.67 |
.60 |
.59 |
.63 |
|
AK033595
| |
AK033595 |
adult male cecum cDNA, RIKEN full-length enriched library, clone:9130022D06 product:unclassifiable, full insert sequence [AK033595] |
KLA | .70 |
.76 |
.71 |
.63 |
.63 |
.64 |
.78 |
| ATP | .98 |
1.07 |
.80 |
.72 |
.93 |
.69 |
.59 |
| KLA/ATP | .72 |
.70 |
.63 |
.67 |
.94 |
.81 |
.57 |
|
Acaca | |
NM_133360 |
acetyl-Coenzyme A carboxylase alpha (Acaca), mRNA [NM_133360] |
KLA | .99 |
.94 |
.95 |
.93 |
.95 |
1.00 |
1.00 |
| ATP | .98 |
.97 |
.96 |
.93 |
.92 |
.96 |
.99 |
| KLA/ATP | 1.01 |
.96 |
.99 |
.92 |
.93 |
.94 |
.91 |
|
Acacb | |
NM_133904 |
acetyl-Coenzyme A carboxylase beta (Acacb), mRNA [NM_133904] |
KLA | 1.01 |
.93 |
1.00 |
.99 |
.95 |
1.03 |
.92 |
| ATP | .96 |
1.04 |
1.05 |
.98 |
1.04 |
1.11 |
1.05 |
| KLA/ATP | .90 |
1.01 |
1.05 |
1.03 |
.97 |
.96 |
1.08 |
|
Acat1 | |
NM_144784 |
acetyl-Coenzyme A acetyltransferase 1 (Acat1), nuclear gene encoding mitochondrial protein, mRNA [NM_144784] |
KLA | 1.04 |
.99 |
.95 |
.99 |
.81 |
.83 |
.51 |
| ATP | .89 |
.88 |
1.21 |
.99 |
.67 |
.36 |
.47 |
| KLA/ATP | .86 |
.97 |
1.18 |
.90 |
.64 |
.42 |
.35 |
|
Acat2 | |
NM_009338 |
acetyl-Coenzyme A acetyltransferase 2 (Acat2), mRNA [NM_009338] |
KLA | 1.14 |
1.13 |
1.22 |
1.29 |
1.10 |
.93 |
.81 |
| ATP | 1.04 |
1.05 |
1.16 |
1.35 |
1.20 |
1.53 |
1.16 |
| KLA/ATP | 1.19 |
1.19 |
1.41 |
1.29 |
1.13 |
.92 |
.71 |
|
Acot12 | |
NM_028790 |
acyl-CoA thioesterase 12 (Acot12), mRNA [NM_028790] |
KLA | 1.02 |
1.00 |
1.26 |
.97 |
1.01 |
1.05 |
1.05 |
| ATP | 1.03 |
1.04 |
1.03 |
1.09 |
1.04 |
1.06 |
1.01 |
| KLA/ATP | 1.01 |
.97 |
1.02 |
1.13 |
1.08 |
1.01 |
1.01 |
|
Acss1 | |
NM_080575 |
acyl-CoA synthetase short-chain family member 1 (Acss1), nuclear gene encoding mitochondrial protein, mRNA [NM_080575] |
KLA | .45 |
.41 |
.45 |
.62 |
.70 |
1.05 |
.43 |
| ATP | .95 |
.89 |
1.35 |
.86 |
.81 |
.57 |
.55 |
| KLA/ATP | .38 |
.37 |
.61 |
.51 |
1.13 |
1.17 |
.38 |
|
Acss2 | |
AK003738 |
18-day embryo whole body cDNA, RIKEN full-length enriched library, clone:1110017C11 product:acetyl-Coenzyme A synthetase 1 (AMP forming), full insert sequence. [AK003738] |
KLA | 1.03 |
.94 |
1.02 |
.97 |
.93 |
1.01 |
1.16 |
| ATP | 1.05 |
.97 |
.98 |
1.03 |
.95 |
1.31 |
1.40 |
| KLA/ATP | .88 |
1.02 |
1.01 |
.93 |
.93 |
1.02 |
1.12 |
|
Acss2 | |
NM_019811 |
acyl-CoA synthetase short-chain family member 2 (Acss2), mRNA [NM_019811] |
KLA | 1.19 |
1.23 |
1.40 |
1.49 |
1.68 |
1.67 |
1.82 |
| ATP | 1.10 |
1.19 |
1.13 |
1.16 |
1.06 |
3.14 |
2.63 |
| KLA/ATP | 1.27 |
1.35 |
1.37 |
1.42 |
1.47 |
3.47 |
2.86 |
|
Acyp1 | |
NM_025421 |
acylphosphatase 1, erythrocyte (common) type (Acyp1), mRNA [NM_025421] |
KLA | .81 |
.79 |
.78 |
.79 |
.65 |
.61 |
.69 |
| ATP | .91 |
.87 |
1.45 |
1.34 |
1.19 |
.60 |
.74 |
| KLA/ATP | .77 |
.88 |
1.30 |
1.16 |
1.05 |
.53 |
.67 |
|
Acyp2 | |
NM_029344 |
acylphosphatase 2, muscle type (Acyp2), mRNA [NM_029344] |
KLA | 1.64 |
1.48 |
1.74 |
1.82 |
1.61 |
1.81 |
1.76 |
| ATP | .88 |
.97 |
1.21 |
1.19 |
.93 |
1.14 |
1.46 |
| KLA/ATP | 1.30 |
1.44 |
1.41 |
1.59 |
1.52 |
1.28 |
1.56 |
|
Akr1b3 | |
AK054167 |
2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230024H01 product:unclassifiable, full insert sequence [AK054167] |
KLA | 1.06 |
.92 |
.98 |
1.01 |
1.02 |
1.04 |
.96 |
| ATP | 1.08 |
1.02 |
.99 |
.97 |
1.09 |
1.02 |
.99 |
| KLA/ATP | .99 |
1.01 |
.97 |
.99 |
1.02 |
.99 |
1.08 |
|
Akr1b3 | |
NM_009658 |
aldo-keto reductase family 1, member B3 (aldose reductase) (Akr1b3), mRNA [NM_009658] |
KLA | .97 |
.99 |
.96 |
.91 |
.92 |
.93 |
.77 |
| ATP | 1.08 |
1.13 |
1.09 |
1.15 |
1.00 |
1.03 |
1.18 |
| KLA/ATP | 1.06 |
.98 |
.95 |
1.15 |
.89 |
.88 |
.82 |
|
Akr1b7 | |
NM_009731 |
aldo-keto reductase family 1, member B7 (Akr1b7), mRNA [NM_009731] |
KLA | .92 |
.93 |
.93 |
.93 |
.97 |
.96 |
.84 |
| ATP | .97 |
1.01 |
.93 |
.88 |
.85 |
.95 |
.88 |
| KLA/ATP | .86 |
.92 |
.92 |
.82 |
.85 |
.94 |
1.02 |
|
Akr1b8 | |
NM_008012 |
aldo-keto reductase family 1, member B8 (Akr1b8), mRNA [NM_008012] |
KLA | .64 |
.56 |
.49 |
.46 |
.31 |
.25 |
.25 |
| ATP | .95 |
.97 |
1.17 |
.90 |
.85 |
2.25 |
2.02 |
| KLA/ATP | .55 |
.53 |
.63 |
.47 |
.50 |
1.00 |
2.18 |
|
Aldh1b1 | |
NM_028270 |
aldehyde dehydrogenase 1 family, member B1 (Aldh1b1), nuclear gene encoding mitochondrial protein, mRNA [NM_028270] |
KLA | 7.51 |
7.83 |
9.27 |
11.57 |
11.10 |
10.78 |
4.79 |
| ATP | .93 |
.91 |
.90 |
.89 |
.73 |
2.27 |
2.30 |
| KLA/ATP | 6.45 |
7.40 |
9.33 |
9.54 |
8.82 |
12.15 |
10.67 |
|
Aldh2 | |
AK163452 |
adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230105J09 product:aldehyde dehydrogenase 2, mitochondrial, full insert sequence [AK163452] |
KLA | .62 |
.65 |
.59 |
.60 |
.63 |
.64 |
.49 |
| ATP | 1.01 |
.91 |
1.06 |
.93 |
1.18 |
.93 |
.41 |
| KLA/ATP | .70 |
.68 |
.70 |
.84 |
1.16 |
.96 |
.45 |
|
Aldh2 | |
NM_009656 |
aldehyde dehydrogenase 2, mitochondrial (Aldh2), nuclear gene encoding mitochondrial protein, mRNA [NM_009656] |
KLA | .74 |
.81 |
.77 |
.65 |
.60 |
.53 |
.50 |
| ATP | .98 |
1.10 |
.90 |
1.17 |
1.04 |
.82 |
.60 |
| KLA/ATP | .84 |
.86 |
.77 |
.82 |
.72 |
.66 |
.51 |
|
Aldh3a2 | |
NM_007437 |
aldehyde dehydrogenase family 3, subfamily A2 (Aldh3a2), mRNA [NM_007437] |
KLA | .86 |
.83 |
.79 |
.79 |
.80 |
.97 |
1.00 |
| ATP | .93 |
.98 |
.94 |
.89 |
.77 |
.87 |
1.02 |
| KLA/ATP | .78 |
.81 |
.67 |
.72 |
.65 |
.81 |
.97 |
|
Aldh7a1 | |
NM_138600 |
aldehyde dehydrogenase family 7, member A1 (Aldh7a1), mRNA [NM_138600] |
KLA | .98 |
1.03 |
1.08 |
1.12 |
1.08 |
.94 |
.99 |
| ATP | 1.01 |
1.03 |
1.00 |
1.03 |
.98 |
.82 |
.91 |
| KLA/ATP | 1.15 |
1.12 |
1.01 |
1.02 |
.90 |
.89 |
.83 |
|
Aldh9a1 | |
NM_019993 |
aldehyde dehydrogenase 9, subfamily A1 (Aldh9a1), mRNA [NM_019993] |
KLA | .64 |
.64 |
.67 |
.48 |
.42 |
.24 |
.33 |
| ATP | 1.07 |
1.02 |
.75 |
.94 |
.68 |
.46 |
.42 |
| KLA/ATP | .72 |
.65 |
.43 |
.55 |
.37 |
.31 |
.24 |
|
Dlat | |
NM_145614 |
dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex) (Dlat), mRNA [NM_145614] |
KLA | 1.00 |
1.05 |
1.03 |
.95 |
.87 |
.83 |
1.15 |
| ATP | .94 |
1.01 |
1.22 |
1.09 |
.80 |
.57 |
.91 |
| KLA/ATP | .96 |
1.01 |
1.05 |
.98 |
.70 |
.48 |
.54 |
|
Dld | |
NM_007861 |
dihydrolipoamide dehydrogenase (Dld), mRNA [NM_007861] |
KLA | 1.60 |
1.66 |
1.84 |
1.66 |
1.47 |
1.16 |
1.17 |
| ATP | 1.05 |
1.08 |
1.21 |
1.06 |
1.15 |
1.24 |
.93 |
| KLA/ATP | 1.52 |
1.63 |
1.65 |
1.42 |
1.17 |
1.05 |
.79 |
|
Dld | |
U73445 |
dihydrolipoamide dehydrogenase (Dld) mRNA, complete cds. [U73445] |
KLA | 1.48 |
1.43 |
1.43 |
1.47 |
1.25 |
1.05 |
1.16 |
| ATP | .94 |
.93 |
1.18 |
.86 |
1.02 |
1.46 |
.97 |
| KLA/ATP | 1.39 |
1.37 |
1.50 |
1.10 |
1.11 |
1.14 |
.85 |
|
Glo1 | |
NM_025374 |
glyoxalase 1 (Glo1), transcript variant 1, mRNA [NM_025374] |
KLA | .94 |
.95 |
.91 |
.85 |
.76 |
.66 |
.70 |
| ATP | .97 |
1.02 |
1.18 |
1.24 |
.98 |
.78 |
.89 |
| KLA/ATP | .92 |
1.01 |
1.09 |
1.07 |
.89 |
.64 |
.59 |
|
Grhpr | |
NM_080289 |
glyoxylate reductase/hydroxypyruvate reductase (Grhpr), mRNA [NM_080289] |
KLA | .82 |
.79 |
.68 |
.60 |
.42 |
.28 |
.56 |
| ATP | .93 |
.99 |
1.24 |
1.33 |
.91 |
.54 |
.71 |
| KLA/ATP | .74 |
.78 |
.84 |
.86 |
.61 |
.31 |
.39 |
|
Hagh | |
NM_024284 |
hydroxyacyl glutathione hydrolase (Hagh), mRNA [NM_024284] |
KLA | .76 |
.69 |
.59 |
.64 |
.53 |
.63 |
.82 |
| ATP | .84 |
.83 |
1.26 |
1.16 |
1.07 |
.79 |
.93 |
| KLA/ATP | .68 |
.73 |
.95 |
.85 |
.92 |
.72 |
.47 |
|
Haghl | |
NM_026897 |
hydroxyacylglutathione hydrolase-like (Haghl), mRNA [NM_026897] |
KLA | .50 |
.47 |
.41 |
.41 |
.38 |
.49 |
1.07 |
| ATP | .86 |
.81 |
.80 |
.85 |
.59 |
.41 |
1.17 |
| KLA/ATP | .46 |
.47 |
.40 |
.44 |
.37 |
.36 |
.68 |
|
Ldha | |
NM_010699 |
lactate dehydrogenase A (Ldha), mRNA [NM_010699] |
KLA | .89 |
.80 |
.84 |
.93 |
.96 |
1.04 |
1.23 |
| ATP | 1.05 |
1.04 |
.96 |
.87 |
1.21 |
1.43 |
1.11 |
| KLA/ATP | .93 |
.87 |
.87 |
.93 |
1.24 |
1.53 |
.96 |
|
Ldhal6b | |
NM_175349 |
lactate dehydrogenase A-like 6B (Ldhal6b), mRNA [NM_175349] |
KLA | .89 |
.90 |
.94 |
.92 |
1.04 |
1.11 |
1.20 |
| ATP | .99 |
.91 |
.90 |
.88 |
.90 |
.88 |
1.17 |
| KLA/ATP | .93 |
.97 |
.87 |
.89 |
.91 |
1.00 |
1.20 |
|
Ldhb | |
NM_008492 |
lactate dehydrogenase B (Ldhb), mRNA [NM_008492] |
KLA | 1.00 |
.97 |
.96 |
1.00 |
.78 |
.63 |
.39 |
| ATP | .84 |
.89 |
1.11 |
1.24 |
1.01 |
.67 |
.47 |
| KLA/ATP | .94 |
1.03 |
1.35 |
1.92 |
1.40 |
.85 |
.47 |
|
Ldhc | |
NM_013580 |
lactate dehydrogenase C (Ldhc), mRNA [NM_013580] |
KLA | .98 |
1.02 |
1.04 |
1.02 |
.97 |
.95 |
.99 |
| ATP | 1.02 |
1.00 |
.97 |
.96 |
1.00 |
1.00 |
.95 |
| KLA/ATP | .96 |
1.10 |
1.07 |
.95 |
1.03 |
1.06 |
1.03 |
|
Ldhd | |
NM_027570 |
lactate dehydrogenase D (Ldhd), nuclear gene encoding mitochondrial protein, mRNA [NM_027570] |
KLA | 1.03 |
.96 |
1.01 |
.94 |
.93 |
.87 |
.94 |
| ATP | 1.01 |
1.04 |
.99 |
.95 |
.92 |
.90 |
1.02 |
| KLA/ATP | 1.04 |
1.01 |
.96 |
.95 |
.91 |
.79 |
.92 |
|
Mdh1 | |
AK077724 |
8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730556L21 product:unclassifiable, full insert sequence [AK077724] |
KLA | .85 |
.75 |
.69 |
.67 |
.72 |
.81 |
.82 |
| ATP | .93 |
.83 |
.61 |
.59 |
.72 |
.72 |
.88 |
| KLA/ATP | .79 |
.76 |
.67 |
.58 |
.74 |
.74 |
.80 |
|
Mdh1 | |
NM_008618 |
malate dehydrogenase 1, NAD (soluble) (Mdh1), mRNA [NM_008618] |
KLA | .79 |
.72 |
.66 |
.66 |
.52 |
.49 |
.57 |
| ATP | .98 |
1.00 |
1.17 |
1.09 |
.96 |
.70 |
.66 |
| KLA/ATP | .70 |
.73 |
.92 |
.78 |
.76 |
.65 |
.52 |
|
Mdh2 | |
NM_008617 |
malate dehydrogenase 2, NAD (mitochondrial) (Mdh2), nuclear gene encoding mitochondrial protein, mRNA [NM_008617] |
KLA | .90 |
.91 |
.81 |
.86 |
.81 |
.91 |
1.26 |
| ATP | .96 |
.86 |
1.04 |
.80 |
1.01 |
1.36 |
1.33 |
| KLA/ATP | .87 |
.79 |
1.04 |
.71 |
.95 |
1.04 |
.95 |
|
Me1 | |
NM_008615 |
malic enzyme 1, NADP(+)-dependent, cytosolic (Me1), mRNA [NM_008615] |
KLA | .95 |
1.01 |
1.01 |
.81 |
.71 |
.71 |
1.97 |
| ATP | .94 |
1.03 |
1.19 |
1.09 |
.93 |
1.48 |
.67 |
| KLA/ATP | .98 |
.96 |
1.04 |
.89 |
.65 |
.87 |
1.05 |
|
Me2 | |
NM_145494 |
malic enzyme 2, NAD(+)-dependent, mitochondrial (Me2), nuclear gene encoding mitochondrial protein, mRNA [NM_145494] |
KLA | .86 |
.82 |
.80 |
.75 |
.64 |
.55 |
.85 |
| ATP | 1.03 |
1.03 |
.80 |
.85 |
.96 |
.89 |
.73 |
| KLA/ATP | .85 |
.80 |
.60 |
.57 |
.79 |
1.03 |
.53 |
|
Me3 | |
AK036221 |
16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630046K15 product:unclassifiable, full insert sequence. [AK036221] |
KLA | 1.04 |
.98 |
.99 |
1.02 |
1.01 |
.99 |
.96 |
| ATP | 1.02 |
1.02 |
1.01 |
.98 |
1.00 |
.95 |
1.04 |
| KLA/ATP | .98 |
.99 |
1.00 |
1.01 |
.99 |
.99 |
1.00 |
|
Me3 | |
NM_181407 |
malic enzyme 3, NADP(+)-dependent, mitochondrial (Me3), nuclear gene encoding mitochondrial protein, mRNA [NM_181407] |
KLA | .97 |
1.00 |
.99 |
.96 |
.94 |
.99 |
.99 |
| ATP | 1.01 |
1.03 |
.98 |
.98 |
.96 |
.95 |
1.03 |
| KLA/ATP | .98 |
1.01 |
.98 |
.96 |
1.00 |
.98 |
.97 |
|
Mm.1845 | |
142351600 |
Unknown |
KLA | .93 |
.92 |
.89 |
.81 |
.76 |
.84 |
.65 |
| ATP | 1.01 |
.94 |
1.08 |
1.00 |
.77 |
1.95 |
1.13 |
| KLA/ATP | .91 |
.84 |
.85 |
.81 |
.59 |
.66 |
.77 |
|
Mm.29323 3 | |
118130035 |
Unknown |
KLA | .98 |
1.04 |
.98 |
1.05 |
1.07 |
.97 |
.95 |
| ATP | 1.02 |
1.04 |
1.01 |
1.02 |
1.00 |
1.00 |
1.00 |
| KLA/ATP | 1.03 |
1.00 |
.98 |
.96 |
1.10 |
1.03 |
.98 |
|
Mm.37812 8 | |
162139826 |
Unknown |
KLA | .94 |
.92 |
.89 |
.82 |
.67 |
.71 |
1.85 |
| ATP | .88 |
.91 |
1.28 |
.99 |
.92 |
1.81 |
.61 |
| KLA/ATP | .85 |
.89 |
1.10 |
.81 |
.72 |
.96 |
1.14 |
|
Pck2 | |
NM_028994 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) (Pck2), nuclear gene encoding mitochondrial protein, mRNA [NM_028994] |
KLA | .40 |
.37 |
.32 |
.28 |
.37 |
.56 |
.55 |
| ATP | .99 |
.96 |
.86 |
.94 |
1.02 |
.57 |
.77 |
| KLA/ATP | .40 |
.37 |
.31 |
.35 |
.42 |
.35 |
.46 |
|
Pcx | |
NM_008797 |
pyruvate carboxylase (Pcx), nuclear gene encoding mitochondrial protein, mRNA [NM_008797] |
KLA | 1.28 |
1.34 |
1.44 |
1.30 |
1.34 |
1.23 |
.91 |
| ATP | 1.11 |
1.09 |
1.19 |
1.29 |
1.19 |
1.49 |
1.16 |
| KLA/ATP | 1.34 |
1.41 |
1.63 |
1.53 |
1.39 |
1.05 |
1.15 |
|
Pdha1 | |
NM_008810 |
pyruvate dehydrogenase E1 alpha 1 (Pdha1), nuclear gene encoding mitochondrial protein, mRNA [NM_008810] |
KLA | .92 |
.96 |
.94 |
.92 |
.94 |
1.04 |
1.18 |
| ATP | .98 |
1.03 |
1.14 |
1.10 |
1.02 |
1.05 |
.91 |
| KLA/ATP | .93 |
.93 |
.97 |
.94 |
.81 |
.82 |
.69 |
|
Pdha2 | |
NM_008811 |
pyruvate dehydrogenase E1 alpha 2 (Pdha2), mRNA [NM_008811] |
KLA | 1.04 |
.95 |
.98 |
.99 |
1.00 |
1.04 |
.98 |
| ATP | 1.00 |
.97 |
.95 |
1.00 |
1.01 |
.99 |
1.01 |
| KLA/ATP | 1.05 |
1.07 |
.91 |
1.02 |
.98 |
1.00 |
1.05 |
|
Pdhb | |
NM_024221 |
pyruvate dehydrogenase (lipoamide) beta (Pdhb), mRNA [NM_024221] |
KLA | 1.14 |
1.05 |
1.00 |
.97 |
1.03 |
.90 |
.88 |
| ATP | 1.08 |
1.10 |
1.12 |
1.23 |
1.24 |
1.24 |
1.21 |
| KLA/ATP | 1.01 |
1.16 |
1.13 |
1.21 |
1.23 |
1.44 |
1.26 |
|
Pdhx | |
NM_175094 |
pyruvate dehydrogenase complex, component X (Pdhx), nuclear gene encoding mitochondrial protein, mRNA [NM_175094] |
KLA | 1.15 |
1.12 |
1.12 |
1.12 |
1.07 |
1.14 |
1.12 |
| ATP | 1.04 |
1.02 |
1.14 |
.94 |
1.03 |
1.30 |
.98 |
| KLA/ATP | 1.25 |
1.20 |
1.26 |
1.05 |
1.08 |
1.38 |
.89 |
|
Pklr | |
NM_013631 |
pyruvate kinase liver and red blood cell (Pklr), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_013631] |
KLA | 1.06 |
1.01 |
1.12 |
1.00 |
.98 |
1.01 |
1.07 |
| ATP | .98 |
.94 |
1.05 |
1.06 |
1.01 |
1.06 |
1.10 |
| KLA/ATP | .97 |
1.00 |
1.04 |
.95 |
.89 |
1.05 |
.97 |
|
Pkm2 | |
D38379 |
mRNA for pyruvate kinase M, complete cds. [D38379] |
KLA | .80 |
.83 |
.94 |
.67 |
.95 |
.95 |
1.42 |
| ATP | 1.22 |
1.30 |
.83 |
1.14 |
.99 |
1.23 |
2.53 |
| KLA/ATP | .99 |
1.03 |
.61 |
.83 |
.70 |
1.16 |
2.54 |
|
Pkm2 | |
NM_011099 |
pyruvate kinase, muscle (Pkm2), mRNA [NM_011099] |
KLA | .84 |
.89 |
.95 |
.72 |
.92 |
1.03 |
1.34 |
| ATP | 1.05 |
1.23 |
.83 |
1.13 |
.96 |
1.20 |
2.14 |
| KLA/ATP | .98 |
.97 |
.64 |
.89 |
.73 |
1.20 |
2.32 |
|